Champions Oncology Shares Rise on Higher 2Q Profit, Revenue

Dow Jones2024-12-12

By Kailyn Rhone

Shares of Champions Oncology jumped after the company swung to a profit and reported higher revenue in the latest quarter due to bookings growth and operational improvements.

The company's stock rose 13% to $6.62 in after-hours trading Wednesday. Shares were up almost 4% for the year through the day's close.

The technology-enabled research company on Wednesday posted a profit of $728,000, or 5 cents a share, up from a loss of $2 million, or 15 cents a share, in the same quarter a year ago.

Sales grew 17% to $13.5 million from $11.6 million a year earlier, driven by growth in bookings and operational improvements and efficiencies implemented in the quarter.

Cost of oncology services rose 12.2% to $7.4 million from $6.6 million a year ago, due to an increase in mice and lab costs to help revenue growth.

"We remain cautiously optimistic that the pharma and biotech environment is improving which will continue to contribute to our long-term growth," Chief Executive Ronnie Morris said.

Write to Kailyn Rhone at kailyn.rhone@wsj.com

(END) Dow Jones Newswires

December 11, 2024 17:32 ET (22:32 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490819185?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-12 06:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490819185","market":"hk","top_or_hot":-1,"title":"Champions Oncology Shares Rise on Higher 2Q Profit, Revenue","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kailyn Rhone \n</p>\n<p>\n  Shares of Champions Oncology jumped after the company swung to a profit and reported higher revenue in the latest quarter due to bookings growth and operational improvements. \n</p>\n<p>\n  The company's stock rose 13% to $6.62 in after-hours trading Wednesday. Shares were up almost 4% for the year through the day's close. \n</p>\n<p>\n  The technology-enabled research company on Wednesday posted a profit of $728,000, or 5 cents a share, up from a loss of $2 million, or 15 cents a share, in the same quarter a year ago. \n</p>\n<p>\n  Sales grew 17% to $13.5 million from $11.6 million a year earlier, driven by growth in bookings and operational improvements and efficiencies implemented in the quarter. \n</p>\n<p>\n  Cost of oncology services rose 12.2% to $7.4 million from $6.6 million a year ago, due to an increase in mice and lab costs to help revenue growth. \n</p>\n<p>\n  \"We remain cautiously optimistic that the pharma and biotech environment is improving which will continue to contribute to our long-term growth,\" Chief Executive Ronnie Morris said. \n</p>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 11, 2024 17:32 ET (22:32 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Champions Oncology Shares Rise on Higher 2Q Profit, Revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChampions Oncology Shares Rise on Higher 2Q Profit, Revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 06:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Kailyn Rhone \n\n\n  Shares of Champions Oncology jumped after the company swung to a profit and reported higher revenue in the latest quarter due to bookings growth and operational improvements. \n\n\n ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSBR","symbol_name":"Champions Oncology, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2490819185","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490819185","pubTimestamp":1733956320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Champions Oncology jumped after the company swung to a profit and reported higher revenue in the latest quarter due to bookings growth and operational improvements.The company's stock rose 13% to $6.62 in after-hours trading Wednesday. Shares were up almost 4% for the year through the day's close.The technology-enabled research company on Wednesday posted a profit of $728,000, or 5 cents a share, up from a loss of $2 million, or 15 cents a share, in the same quarter a year ago.Sales grew 17% to $13.5 million from $11.6 million a year earlier, driven by growth in bookings and operational improvements and efficiencies implemented in the quarter.Cost of oncology services rose 12.2% to $7.4 million from $6.6 million a year ago, due to an increase in mice and lab costs to help revenue growth.\"We remain cautiously optimistic that the pharma and biotech environment is improving which will continue to contribute to our long-term growth,\" Chief Executive Ronnie Morris said.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CSBR":"Champions Oncology, Inc."},"translate_title":"Champions Oncology股价因第二季度利润和收入增加而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSBR":1},"content_text":"By Kailyn Rhone \n\n\n  Shares of Champions Oncology jumped after the company swung to a profit and reported higher revenue in the latest quarter due to bookings growth and operational improvements. \n\n\n  The company's stock rose 13% to $6.62 in after-hours trading Wednesday. Shares were up almost 4% for the year through the day's close. \n\n\n  The technology-enabled research company on Wednesday posted a profit of $728,000, or 5 cents a share, up from a loss of $2 million, or 15 cents a share, in the same quarter a year ago. \n\n\n  Sales grew 17% to $13.5 million from $11.6 million a year earlier, driven by growth in bookings and operational improvements and efficiencies implemented in the quarter. \n\n\n  Cost of oncology services rose 12.2% to $7.4 million from $6.6 million a year ago, due to an increase in mice and lab costs to help revenue growth. \n\n\n  \"We remain cautiously optimistic that the pharma and biotech environment is improving which will continue to contribute to our long-term growth,\" Chief Executive Ronnie Morris said. \n\n\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2024 17:32 ET (22:32 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490819185"}